Risultati finali
In order to link DRIVE to society through science-society dialogues on chances, risks and ethical aspects of DRIVE, patient and citizen panels will be organised in the framework of WP8. In order to overcome the classical one-way communication with scientists in the role of experts providing information and public in the role of lay-people receiving information, engaging in a two-way dialogue at eye level between scientists and patients/public is DRIVE’s goal.
Report on patient advocacy activitiesDRIVE is committed to supporting diabetes patient advocacy groups across the consortiums member countries and indeed across Europe. This task will be managed by NUIG and contributed to by all DRIVE partners who will contact the major diabetes patient advocacy groups in their home countries. The DRIVE consortium will raise the awareness of the importance of diabetes as a problem in modern society through the participation in public events, open lectures and free to attend conferences and support the lobbying of governments by advocacy groups for increased funding towards diabetes research and diabetes services for patients.
Dissemination and Data Management Plan (DMP) and introductory project dissemination materialThis task will be initiated by the development of a dissemination and Data Management Plan (DMP), agreed among the partners, that will describe the data to be generated, how they will be recorded, collected, processed, curated, reported and archived and how they will be made accessible for use. INN will have the responsibility to set up this plan which will be approved by the General Assembly.
A project website will be set up by INN to support the dissemination activities of the project, providing up-to-date information about the project and its results to the public .
Pubblicazioni
Autori:
Alan J .Ryan, Hugh S O’Neill, Garry P Duffy, Fergal J O’Brien
Pubblicato in:
Current Opinion in Pharmacology, Numero 36, 2017, Pagina/e 66-71, ISSN 1471-4892
Editore:
Elsevier BV
DOI:
10.1016/j.coph.2017.07.013
Autori:
Albert Espona-Noguera, Jesús Ciriza, Alberto Cañibano-Hernández, Luis Fernandez, Ignacio Ochoa, Laura Saenz del Burgo, Jose Luis Pedraz
Pubblicato in:
International Journal of Biological Macromolecules, Numero 107, 2018, Pagina/e 1261-1269, ISSN 0141-8130
Editore:
Elsevier BV
DOI:
10.1016/j.ijbiomac.2017.09.103
Autori:
Bertuzzi F, Colussi G, Lauterio A, De Carlis L.
Pubblicato in:
Eur Rev Med Pharmacol Sci, 2018, ISSN 1128-3602
Editore:
Verduci Editore srl
DOI:
10.26355/eurrev_201803_14588
Autori:
S. Acreman, H. Brandhorst, A. Abraham, P.R.V. Johnson, D. Brandhorst
Pubblicato in:
Transplantation Proceedings, Numero 49/10, 2017, Pagina/e 2327-2329, ISSN 0041-1345
Editore:
Appleton & Lange
DOI:
10.1016/j.transproceed.2017.11.002
Autori:
Federico Bertuzzi, Luciano De Carlis, Mario Marazzi, Antonio Gaetano Rampoldi, Matteo Bonomo, Barbara Antonioli, Marta Cecilia Tosca, Marta Galuzzi, Andrea Lauterio, Danila Fava, Patrizia Dorighet, Andrea De Gasperi, Giacomo Colussi
Pubblicato in:
Cell Transplantation, Numero 27/5, 2018, Pagina/e 840-846, ISSN 0963-6897
Editore:
Cognizant Communication Corp.
DOI:
10.1177/0963689718763751
Autori:
Aline Zbinden, Julia Marzi, Katharina Schlünder, Christopher Probst, Max Urbanczyk, Scott Black, Eva M. Brauchle, Shannon L. Layland, Udo Kraushaar, Garry Duffy, Katja Schenke-Layland, Peter Loskill
Pubblicato in:
Matrix Biology, 2019, ISSN 0945-053X
Editore:
Elsevier BV
DOI:
10.1016/j.matbio.2019.06.008
Autori:
Karina C. Scheiner, Roel F. Maas-Bakker, Thanh T. Nguyen, Ana M. Duarte, Gert Hendriks, Lídia Sequeira, Garry P. Duffy, Rob Steendam, Wim E. Hennink, Robbert J. Kok
Pubblicato in:
ACS Omega, Numero 4/7, 2019, Pagina/e 11481-11492, ISSN 2470-1343
Editore:
ACS Publications
DOI:
10.1021/acsomega.9b01272
Diritti di proprietà intellettuale
Numero candidatura/pubblicazione:
PCT
/EP2018/061513
Data:
2017-05-29
Numero candidatura/pubblicazione:
PCT
/US2017/054142
Data:
2017-09-28
Candidato/i:
BOSTON SCIENTIFIC LIMITED
Numero candidatura/pubblicazione:
PCT
/EP2018/061513
Data:
2017-05-29
Numero candidatura/pubblicazione:
PCT
/US2017/054142
Data:
2017-09-28
Candidato/i:
BOSTON SCIENTIFIC LIMITED
Numero candidatura/pubblicazione:
PCT
62/400,754
Data:
2017-09-27
Candidato/i:
BOSTON SCIENTIFIC LIMITED
Numero candidatura/pubblicazione:
PCT
62/400,754
Data:
2017-09-27
Candidato/i:
BOSTON SCIENTIFIC LIMITED
È in corso la ricerca di dati su OpenAIRE...
Si è verificato un errore durante la ricerca dei dati su OpenAIRE
Nessun risultato disponibile